259 related articles for article (PubMed ID: 25517598)
1. Role of inflammasomes in intestinal inflammation and Crohn's disease.
Opipari A; Franchi L
Inflamm Bowel Dis; 2015 Jan; 21(1):173-81. PubMed ID: 25517598
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
3. Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease.
Xu Q; Zhou X; Strober W; Mao L
Molecules; 2021 Mar; 26(6):. PubMed ID: 33808793
[TBL] [Abstract][Full Text] [Related]
4. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.
Shao BZ; Wang SL; Pan P; Yao J; Wu K; Li ZS; Bai Y; Linghu EQ
Inflammation; 2019 Aug; 42(4):1147-1159. PubMed ID: 30937839
[TBL] [Abstract][Full Text] [Related]
5. Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health.
Ranson N; Kunde D; Eri R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120406
[TBL] [Abstract][Full Text] [Related]
6. Inflammasomes in inflammatory bowel disease pathogenesis.
Hao LY; Liu X; Franchi L
Curr Opin Gastroenterol; 2013 Jul; 29(4):363-9. PubMed ID: 23689522
[TBL] [Abstract][Full Text] [Related]
7. [Intestinal flora and Crohn's disease].
Desreumaux P; Colombel JF
Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
[TBL] [Abstract][Full Text] [Related]
8. The inflammasomes and autoinflammatory syndromes.
Broderick L; De Nardo D; Franklin BS; Hoffman HM; Latz E
Annu Rev Pathol; 2015; 10():395-424. PubMed ID: 25423351
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential.
Xu Q; Sun W; Zhang J; Mei Y; Bao J; Hou S; Zhou X; Mao L
Front Immunol; 2022; 13():963291. PubMed ID: 36090968
[TBL] [Abstract][Full Text] [Related]
10. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
[TBL] [Abstract][Full Text] [Related]
11. Metabolome and inflammasome in inflammatory bowel disease.
Nanau RM; Neuman MG
Transl Res; 2012 Jul; 160(1):1-28. PubMed ID: 22687960
[TBL] [Abstract][Full Text] [Related]
12. The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models.
Aguilera M; Darby T; Melgar S
Cytokine Growth Factor Rev; 2014 Dec; 25(6):715-30. PubMed ID: 24803013
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
Däbritz J
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
[TBL] [Abstract][Full Text] [Related]
14. Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota.
Gagliani N; Palm NW; de Zoete MR; Flavell RA
Int Immunol; 2014 Sep; 26(9):495-9. PubMed ID: 24948595
[TBL] [Abstract][Full Text] [Related]
15. Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
Lazaridis LD; Pistiki A; Giamarellos-Bourboulis EJ; Georgitsi M; Damoraki G; Polymeros D; Dimitriadis GD; Triantafyllou K
Dig Dis Sci; 2017 Sep; 62(9):2348-2356. PubMed ID: 28523573
[TBL] [Abstract][Full Text] [Related]
16. NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease.
Zhang J; Zeng S; Wang P; Chen Y; Zeng C
Curr Drug Targets; 2023; 24(14):1106-1116. PubMed ID: 37946354
[TBL] [Abstract][Full Text] [Related]
17. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
18. Autophagy limits activation of the inflammasomes.
Takahama M; Akira S; Saitoh T
Immunol Rev; 2018 Jan; 281(1):62-73. PubMed ID: 29248000
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases.
Mason DR; Beck PL; Muruve DA
J Innate Immun; 2012; 4(1):16-30. PubMed ID: 22067846
[TBL] [Abstract][Full Text] [Related]
20. [Barrier- and autophagic functions of the intestinal epithelia: role of disturbances in the pathogenesis of Crohn's disease].
Lapis K
Orv Hetil; 2010 Oct; 151(40):1645-55. PubMed ID: 20860961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
